Clinical trial
Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of…
NCT00427505 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00427505 |
|---|---|
| Title | Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam |
| Official title | An Open-label, One-sequence Cross-over Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam in Healthy Volunteers |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Deferasirox |
| Enrollment | 22 |
| Start date | Jul 1, 2006 |
| First posted | Jan 29, 2007 |
| Last update posted | Nov 19, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: